AtriCure Net Debt from 2010 to 2026

ATRC Stock

USD 37.11 0.91 2.51%

AtriCure's Net Debt is decreasing over the years with slightly volatile fluctuation. Overall, Net Debt is projected to go to about -50.5 M this year. Net Debt is the total debt of AtriCure minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2004-12-31

Previous Quarter

-40.5 M

Current Value

-71.1 M

Quarterly Volatility

25.3 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check AtriCure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AtriCure's main balance sheet or income statement drivers, such as Interest Expense of 7.7 M, Total Revenue of 561.9 M or Gross Profit of 419.6 M, as well as many indicators such as Price To Sales Ratio of 3.37, Dividend Yield of 0.0 or PTB Ratio of 3.71. AtriCure financial statements analysis is a perfect complement when working with AtriCure Valuation or Volatility modules.

Build AI portfolio with AtriCure Stock

Check out the analysis of AtriCure Correlation against competitors.

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

Analyzing AtriCure's Net Debt over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Debt has evolved provides context for assessing AtriCure's current valuation and future prospects.

Latest AtriCure's Net Debt Growth Pattern

Below is the plot of the Net Debt of AtriCure over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. AtriCure's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AtriCure's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

AtriCure Net Debt Regression Statistics

	Arithmetic Mean	(1,810,751)
	Coefficient Of Variation	(1,623)
	Mean Deviation	22,839,295
	Median	(3,290,280)
	Standard Deviation	29,394,439
	Sample Variance	864T
	Range	101.1M
	R-Value	(0.27)
	Mean Square Error	853.8T
	R-Squared	0.07
	Significance	0.29
	Slope	(1,579,055)
	Total Sum of Squares	13824.5T

AtriCure Net Debt History

	2026	-50.5 M
	2025	-53.1 M
	2024	-46.2 M
	2023	-9.8 M
	2022	16.4 M
	2021	32 M
	2020	32.1 M

Other Fundumenentals of AtriCure

Net Debt To E B I T D A

AtriCure Net Debt component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Accounts Payable	Common Stock	Property Plant Equipment	Net Debt	Net Receivables	Total Current Assets	Long Term Debt	Good Will	Short Term Investments	Short Term Debt	Intangible Assets	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.97	-0.95	0.83	0.87	0.85	0.91	-0.08	0.83	0.95	0.97	0.99	0.42	0.49	0.7	-0.33	0.6	0.88	0.92	0.23	0.35	0.9	0.88	0.81
Total Stockholder Equity	0.97		-0.93	0.66	0.92	0.83	0.92	-0.23	0.9	0.96	0.95	0.96	0.3	0.43	0.51	-0.3	0.78	0.83	0.92	0.28	0.3	0.94	0.87	0.88
Retained Earnings	-0.95	-0.93		-0.75	-0.9	-0.91	-0.91	0.14	-0.86	-0.93	-0.94	-0.94	-0.32	-0.47	-0.64	0.49	-0.61	-0.89	-0.92	-0.11	-0.28	-0.87	-0.85	-0.79
Total Liab	0.83	0.66	-0.75		0.55	0.68	0.66	0.28	0.49	0.71	0.79	0.82	0.58	0.51	0.95	-0.31	0.06	0.78	0.69	0.06	0.36	0.59	0.68	0.45
Accounts Payable	0.87	0.92	-0.9	0.55		0.76	0.92	-0.43	0.97	0.87	0.89	0.89	-0.02	0.18	0.4	-0.37	0.74	0.72	0.81	0.05	0.2	0.85	0.74	0.88
Common Stock	0.85	0.83	-0.91	0.68	0.76		0.83	0.01	0.7	0.79	0.8	0.83	0.38	0.47	0.65	-0.52	0.52	0.89	0.94	0.24	0.34	0.79	0.75	0.69
Property Plant Equipment	0.91	0.92	-0.91	0.66	0.92	0.83		-0.21	0.89	0.85	0.91	0.93	0.13	0.24	0.56	-0.34	0.63	0.83	0.85	0.13	0.38	0.79	0.7	0.77
Net Debt	-0.08	-0.23	0.14	0.28	-0.43	0.01	-0.21		-0.55	-0.27	-0.09	-0.08	0.6	0.16	0.38	-0.06	-0.54	0.17	-0.04	0.45	0.09	-0.21	-0.18	-0.5
Net Receivables	0.83	0.9	-0.86	0.49	0.97	0.7	0.89	-0.55		0.87	0.87	0.85	-0.09	0.2	0.32	-0.3	0.77	0.68	0.76	-0.03	0.12	0.83	0.74	0.9
Total Current Assets	0.95	0.96	-0.93	0.71	0.87	0.79	0.85	-0.27	0.87		0.92	0.92	0.4	0.58	0.57	-0.3	0.71	0.79	0.88	0.09	0.29	0.91	0.95	0.87
Long Term Debt	0.97	0.95	-0.94	0.79	0.89	0.8	0.91	-0.09	0.87	0.92		0.98	0.29	0.37	0.64	-0.32	0.6	0.91	0.89	0.22	0.21	0.91	0.84	0.83
Good Will	0.99	0.96	-0.94	0.82	0.89	0.83	0.93	-0.08	0.85	0.92	0.98		0.33	0.39	0.69	-0.3	0.58	0.89	0.91	0.24	0.32	0.89	0.83	0.81
Short Term Investments	0.42	0.3	-0.32	0.58	-0.02	0.38	0.13	0.6	-0.09	0.4	0.29	0.33		0.8	0.61	-0.13	0.0	0.42	0.42	0.33	0.38	0.32	0.52	0.04
Short Term Debt	0.49	0.43	-0.47	0.51	0.18	0.47	0.24	0.16	0.2	0.58	0.37	0.39	0.8		0.45	-0.25	0.25	0.39	0.49	0.11	0.34	0.45	0.67	0.31
Intangible Assets	0.7	0.51	-0.64	0.95	0.4	0.65	0.56	0.38	0.32	0.57	0.64	0.69	0.61	0.45		-0.25	-0.11	0.73	0.63	-0.01	0.45	0.44	0.58	0.29
Current Deferred Revenue	-0.33	-0.3	0.49	-0.31	-0.37	-0.52	-0.34	-0.06	-0.3	-0.3	-0.32	-0.3	-0.13	-0.25	-0.25		-0.14	-0.32	-0.31	-0.06	-0.18	-0.24	-0.24	-0.2
Net Tangible Assets	0.6	0.78	-0.61	0.06	0.74	0.52	0.63	-0.54	0.77	0.71	0.6	0.58	0.0	0.25	-0.11	-0.14		0.44	0.64	0.3	0.07	0.78	0.65	0.81
Long Term Debt Total	0.88	0.83	-0.89	0.78	0.72	0.89	0.83	0.17	0.68	0.79	0.91	0.89	0.42	0.39	0.73	-0.32	0.44		0.93	0.29	0.21	0.82	0.78	0.68
Capital Surpluse	0.92	0.92	-0.92	0.69	0.81	0.94	0.85	-0.04	0.76	0.88	0.89	0.91	0.42	0.49	0.63	-0.31	0.64	0.93		0.31	0.31	0.93	0.87	0.82
Long Term Investments	0.23	0.28	-0.11	0.06	0.05	0.24	0.13	0.45	-0.03	0.09	0.22	0.24	0.33	0.11	-0.01	-0.06	0.3	0.29	0.31		0.04	0.34	0.11	0.11
Short Long Term Debt	0.35	0.3	-0.28	0.36	0.2	0.34	0.38	0.09	0.12	0.29	0.21	0.32	0.38	0.34	0.45	-0.18	0.07	0.21	0.31	0.04		0.18	0.3	0.1
Net Invested Capital	0.9	0.94	-0.87	0.59	0.85	0.79	0.79	-0.21	0.83	0.91	0.91	0.89	0.32	0.45	0.44	-0.24	0.78	0.82	0.93	0.34	0.18		0.91	0.93
Net Working Capital	0.88	0.87	-0.85	0.68	0.74	0.75	0.7	-0.18	0.74	0.95	0.84	0.83	0.52	0.67	0.58	-0.24	0.65	0.78	0.87	0.11	0.3	0.91		0.84
Capital Stock	0.81	0.88	-0.79	0.45	0.88	0.69	0.77	-0.5	0.9	0.87	0.83	0.81	0.04	0.31	0.29	-0.2	0.81	0.68	0.82	0.11	0.1	0.93	0.84

Click cells to compare fundamentals

About AtriCure Financial Statements

AtriCure stakeholders use historical fundamental indicators, such as AtriCure's Net Debt, to determine how well the company is positioned to perform in the future. Although AtriCure investors may analyze each financial statement separately, they are all interrelated. For example, changes in AtriCure's assets and liabilities are reflected in the revenues and expenses on AtriCure's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AtriCure. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	-53.1 M	-50.5 M
Net Debt To EBITDA	2.87	3.01

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:

How To Invest In AtriCure

Details

Is AtriCure Stock a good investment?

Details

What is AtriCure's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of AtriCure Correlation against competitors.

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Will Health Care Equipment & Supplies sector continue expanding? Could AtriCure diversify its offerings? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AtriCure data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Earnings Share

(0.61)

Revenue Per Share

10.902

Quarterly Revenue Growth

0.158

Return On Assets

(0.03)

Return On Equity

(0.06)

Understanding AtriCure requires distinguishing between market price and book value, where the latter reflects AtriCure's accounting equity. The concept of intrinsic value - what AtriCure's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push AtriCure's price substantially above or below its fundamental value.

Understanding that AtriCure's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AtriCure represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, AtriCure's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

AtriCure Net Debt from 2010 to 2026

Latest AtriCure's Net Debt Growth Pattern

AtriCure Net Debt Regression Statistics

AtriCure Net Debt History

Other Fundumenentals of AtriCure

AtriCure Net Debt component correlations

About AtriCure Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY